Egawa Y, Suzuki I, Nagi N, Yadomae T, Kawakita T, Kikuchi S, Nomoto K
Laboratory of Immunopharmacology of Microbial Products, Tokyo College of Pharmacy, Japan.
Int J Immunopharmacol. 1991;13(7):1031-6. doi: 10.1016/0192-0561(91)90058-f.
Immunomodulating and anti-tumor activities of orally administered Chai-Ling-Tang (Japanese name: sairei-to, ST) were investigated. The oral administration of ST into mice augmented the antibody response to intraperitoneally administered 2, 4, 6-trinitrophenyl-haptenated sheep red blood cells (TNP-SRBC). Orally administered ST showed also an enhancing effect on the antibody response to TNP-SRBC administered by the oral route. In addition, orally administered ST markedly activated the peritoneal macrophages to enhanced phagocytic and lysosomal enzyme activities. A significant inhibition of tumor growth was observed in a syngeneic tumor-mouse system when ST was administered orally. These results suggest that ST has an efficiency as an oral adjuvant or an oral biological response modifier (BRM).
研究了口服柴苓汤(日语名称:柴苓汤,ST)的免疫调节和抗肿瘤活性。给小鼠口服ST可增强对腹腔注射2,4,6-三硝基苯基半抗原化绵羊红细胞(TNP-SRBC)的抗体反应。口服ST对口服给予的TNP-SRBC的抗体反应也有增强作用。此外,口服ST可显著激活腹腔巨噬细胞,增强吞噬和溶酶体酶活性。在同基因肿瘤小鼠系统中,口服ST时可观察到肿瘤生长受到显著抑制。这些结果表明,ST作为口服佐剂或口服生物反应调节剂(BRM)具有有效性。